For #Parkinsons patients, in addition to the more well known motor symptoms, up to 50% of patients also suffer from excessive daytime sleepiness. This can have a significant effect on the quality of life of both the patient and their caregiver, and in some cases be even more profound than the motor symptoms.
A new clinical research study is looking at the safety and efficacy of an investigational medication for excessive daytime sleepiness in patients with Parkinson’s disease (PD). For patients who meet the study criteria, the trial will last about 9 weeks and involve 7 visits to the study center. Qualified participants will be provided compensation for time and travel.
